{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:43:48Z","timestamp":1761709428912,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vascn.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T14:55:05Z","timestamp":1515509705000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The evaluation of drug-induced changes in left ventricular function in pentobarbital-anesthetized dogs"],"prefix":"10.1016","volume":"91","author":[{"given":"Yevgeniya E.","family":"Koshman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett R.","family":"Herzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terese R.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Polakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Mittelstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2018.01.002_bb0005","first-page":"E21","article-title":"Atenolol quantification in human plasma by high-performance liquid chromatography: application to bioequivalence study","volume":"5","author":"de Abreu","year":"2003","journal-title":"AAPS Pharmacological Society"},{"key":"10.1016\/j.vascn.2018.01.002_bb0010","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole","volume":"357","author":"Ahmad","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vascn.2018.01.002_bb0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.RES.45.5.666","article-title":"Cardiotonic activity of amrinone\u2014win 40680 [5-amino-3,4\u2032-bipyridine-6(1h)-one]","volume":"45","author":"Alousi","year":"1979","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2018.01.002_bb0020","first-page":"10","article-title":"Pharmacology of the bipyridines: amrinone and milrinone","volume":"73","author":"Alousi","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2018.01.002_bb0025","first-page":"36791","article-title":"Ichs7a: Safety pharmacology studies for human pharmaceuticals","volume":"66","author":"Anon.","year":"2001","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2018.01.002_bb0030","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.01181.2007","article-title":"Comparative effects of levosimendan, or-1896, or-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs","volume":"294","author":"Banfor","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"1 Pt 1","key":"10.1016\/j.vascn.2018.01.002_bb0035","first-page":"E95","article-title":"Pentobarbital effects on plasma catecholamines: Temperature, heart rate, and blood pressure","volume":"248","author":"Baum","year":"1985","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2018.01.002_bb0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0090-9556(24)15308-1","article-title":"Cardiovascular effect and simultaneous pharmacokinetic and pharmacodynamic modeling of pimobendan in healthy normal subjects","volume":"27","author":"Chu","year":"1999","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.vascn.2018.01.002_bb0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/ajplegacy.1972.223.3.651","article-title":"Influence of pentobarbital anesthesia on cardiovascular function in trained dogs","volume":"223","author":"Cox","year":"1972","journal-title":"The American Journal of Physiology"},{"issue":"2","key":"10.1016\/j.vascn.2018.01.002_bb0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3565(25)33596-2","article-title":"Pharmacokinetics of pentobarbital in the dog","volume":"225","author":"Frederiksen","year":"1983","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2018.01.002_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FJC.0b013e31824485dd","article-title":"Strategic integration of in vivo cardiovascular models during lead optimization: Predictive value of 4 models independent of species, route of administration, and influence of anesthesia","volume":"59","author":"Fryer","year":"2012","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2018.01.002_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0022-3565(25)13394-6","article-title":"Differential effects of d- and l-pimobendan on cardiac myofilament calcium sensitivity","volume":"247","author":"Fujino","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2018.01.002_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.63.5.911","article-title":"Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: Comparison with milrinone","volume":"63","author":"Fujino","year":"1988","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2018.01.002_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vascn.2015.02.002","article-title":"The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a hesi-sponsored consortium","volume":"75","author":"Guth","year":"2015","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2018.01.002_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.1981.54","article-title":"Amrinone metabolism","volume":"29","author":"Kullberg","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.vascn.2018.01.002_bb0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.39.4.512","article-title":"Effects of sodium pentobarbital anesthesia on left ventricular function and distribution of cardiac output in dogs, with particular reference to the mechanism for tachycardia","volume":"39","author":"Manders","year":"1976","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2018.01.002_bb0085","first-page":"S1","article-title":"Hemodynamic profile of the cardiotonic agent pimobendan","volume":"14","author":"van Meel","year":"1989","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5 Pt 2","key":"10.1016\/j.vascn.2018.01.002_bb0090","first-page":"H2135","article-title":"Substantial cardiac parasympathetic activity exists during heavy dynamic exercise in dogs","volume":"273","author":"O'Leary","year":"1997","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2018.01.002_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1091581811398963","article-title":"Cardiovascular function in nonclinical drug safety assessment: Current issues and opportunities","volume":"30","author":"Sarazan","year":"2011","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2018.01.002_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","article-title":"Heart failure induced by non-cardiac drugs","volume":"29","author":"Slordal","year":"2006","journal-title":"Drug Safety"},{"issue":"3 Pt 2","key":"10.1016\/j.vascn.2018.01.002_bb0105","first-page":"H700","article-title":"Does pentobarbital anesthesia depress left ventricular contractility in dogs?","volume":"261","author":"Unruh","year":"1991","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2018.01.002_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the qt interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"Journal of Pharmacological Methods"},{"key":"10.1016\/j.vascn.2018.01.002_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-198326010-00002","article-title":"Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders","volume":"26","author":"Ward","year":"1983","journal-title":"Drugs"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917302174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917302174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:01:28Z","timestamp":1761004888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871917302174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":23,"alternative-id":["S1056871917302174"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2018.01.002","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evaluation of drug-induced changes in left ventricular function in pentobarbital-anesthetized dogs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}